| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18803677 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 100 journal articles in the PubMed database | Email to a friend | | |
| Banerjee A, Wynne K, Tan T, et al.
High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy. [JOURNAL ARTICLE]
Clin Endocrinol (Oxf) 2008 Sep 17.
Full Citation | Publisher Full Text | Find Related Articles | | Verhelst J, Abs R, Maiter D, et al.
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. [Journal Article]
J Clin Endocrinol Metab 1999 Jul; 84(7):2518-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Howell DL, Wasilewski K, Mazewski CM, et al.
The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma. [Journal Article]
J Pediatr Hematol Oncol 2005 Jun; 27(6):326-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | George LD, Nicolau N, Scanlon MF, et al.
Recovery of growth hormone secretion following cabergoline treatment of macroprolactinomas. [Journal Article]
Clin Endocrinol (Oxf) 2000 Nov; 53(5):595-9.
Abstract | Full Citation | Find Related Articles | | Webster J, Piscitelli G, Polli A, et al.
The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group. [Clinical Trial, Journal Article, Multicenter Study]
Clin Endocrinol (Oxf) 1993 Sep; 39(3):323-9.
Abstract | Full Citation | Find Related Articles | | Sabuncu T, Arikan E, Tasan E, et al.
Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Intern Med 2001 Sep; 40(9):857-61.
Abstract | Full Citation | Find Related Articles | | Webster J, Piscitelli G, Polli A, et al.
Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Endocrinol (Oxf) 1992 Dec; 37(6):534-41.
Abstract | Full Citation | Find Related Articles | | Raverot G, Jacob M, Jouanneau E, et al.
Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. [JOURNAL ARTICLE]
Clin Endocrinol (Oxf) 2008 Jul 31.
Abstract | Full Citation | Find Related Articles | | Iglesias P, Macho LP, Díez JJ
Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy. [Case Reports, Journal Article]
Age Ageing 2004 Jul; 33(4):410-2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
